70974 Federal Register / Vol. 71, No. 235 / Thursday, December 7, 2006 / Notices 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The purpose of this 

meeting is to evaluate proposals for 

support through the RAID program by 

making available to the research 

community, on a competitive basis, NCI 

new agent development contract 

resources for the preclinical 

development of drugs and biologics. 

The outcome of the evaluation will be 

a decision whether NCI should support 

the request and make available contract 

resources for support through the RAID 

program to the research community, 

NCI new agent development for the 

preclinical development of drugs and 

biologics. The research proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the 

proposed research projects, the 

disclosure of which would constitute a 

clearly unwarranted invasion of 

personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel Rapid 

Access to Intervention Development. 

Date: December 20, 2006. 

Time: 8:30 a.m.–5 p.m. 

Agenda: To evaluate Rapid Access to 

Intervention Development Portfolio. 

Place: National Institutes of Health, 6130 

Executive Boulevard, Rm. 319, Rockville, MD 

20852. 

Contact Person: Phyllis G. Bryant, 

Executive Secretary, Program Analyst, 

Developmental Therapeutics Program, 

National Cancer Institute, NIH, 6130 

Executive Boulevard, Rm. 8022, Bethesda, 

MD 20892, 301 435–9137. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: November 30, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9577 Filed 12–6–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

Demonstration and Education Research 

Grants. 

Date: December 15, 2006. 

Time: 9 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Patricia A. Haggerty, PhD, 

Scientific Review Administrator, National 

Heart, Lung, and Blood Institute/NIH, 

Clinical Studies & Training Studies Rev. 

Grp., Division of Extramural Affairs/Section 

Chief, 6701 Rockledge Drive, Room 7194, 

Bethesda, MD 20892, 301/435–0288, 

haggertp@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

Coronary Intervention Trial. 

Date: December 19, 2006. 

Time: 12 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: William J. Johnson, PhD, 

Scientific Review Administrator, Review 

Branch, Division of Extramural Research 

Activities, NIH/NHLBI, 6701 Rockledge 

Drive, Bethesda, MD 20892–7924, 301–435–

0317, johnsonw@nhlbi.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: December 1, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9573 Filed 12–6–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Inherited 

Disease Research Access Committee Group 

A. 

Date: January 5, 2007. 

Time: 8:30 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Jerry Roberts, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, National Institutes of Health, 

Building 38A, Bethesda, MD 20892, 301 402–

0838. 

Name of Committee: Center for Inherited 

Disease Research Access Committee Group B. 

Date: January 5, 2007. 

Time: 3:15 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Rudy Pozzatti, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, National Human Genome 

Research Institute, 5635 Fishers Lane, Suite 

4076, MSC 9306, Bethesda, MD 20852, (301) 

402–0838, pozzattr@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.172, Human Genome 

Research, National Institutes of Health, HHS) 


sroberts on PROD1PC70 with NOTICES